External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

HSG 2022

-
Coming soon
04:00 PM
Duration 15mins Main Ballroom
GENERATION HD2, a Phase II dose-finding study of tominersen
Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar